nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PTGS2—pancreatic cancer	0.633	1	CbGaD
Drospirenone—BCHE—Irinotecan—pancreatic cancer	0.0473	1	CbGbCtD
Drospirenone—Thromboembolic event—Tamoxifen—pancreatic cancer	0.0109	0.0542	CcSEcCtD
Drospirenone—Thromboembolic event—Sunitinib—pancreatic cancer	0.00936	0.0464	CcSEcCtD
Drospirenone—Infarction—Sunitinib—pancreatic cancer	0.00908	0.045	CcSEcCtD
Drospirenone—Cerebral infarction—Sunitinib—pancreatic cancer	0.00773	0.0383	CcSEcCtD
Drospirenone—Thromboembolic event—Irinotecan—pancreatic cancer	0.00771	0.0382	CcSEcCtD
Drospirenone—Loss of libido—Tamoxifen—pancreatic cancer	0.00637	0.0316	CcSEcCtD
Drospirenone—Cerebral infarction—Irinotecan—pancreatic cancer	0.00637	0.0316	CcSEcCtD
Drospirenone—Thromboembolic event—Docetaxel—pancreatic cancer	0.00533	0.0264	CcSEcCtD
Drospirenone—Embolism—Tamoxifen—pancreatic cancer	0.00458	0.0227	CcSEcCtD
Drospirenone—Thrombosis—Tamoxifen—pancreatic cancer	0.00416	0.0206	CcSEcCtD
Drospirenone—Embolism—Sunitinib—pancreatic cancer	0.00393	0.0195	CcSEcCtD
Drospirenone—Thrombosis—Sunitinib—pancreatic cancer	0.00356	0.0176	CcSEcCtD
Drospirenone—Breast pain—Tamoxifen—pancreatic cancer	0.00337	0.0167	CcSEcCtD
Drospirenone—Venous thromboembolism—Epirubicin—pancreatic cancer	0.00329	0.0163	CcSEcCtD
Drospirenone—Embolism—Irinotecan—pancreatic cancer	0.00323	0.016	CcSEcCtD
Drospirenone—Venous thromboembolism—Doxorubicin—pancreatic cancer	0.00305	0.0151	CcSEcCtD
Drospirenone—Thrombosis—Irinotecan—pancreatic cancer	0.00293	0.0145	CcSEcCtD
Drospirenone—Embolism—Docetaxel—pancreatic cancer	0.00224	0.0111	CcSEcCtD
Drospirenone—Cerebrovascular accident—Erlotinib—pancreatic cancer	0.00216	0.0107	CcSEcCtD
Drospirenone—Mood swings—Tamoxifen—pancreatic cancer	0.00202	0.01	CcSEcCtD
Drospirenone—Embolism venous—Epirubicin—pancreatic cancer	0.00192	0.00951	CcSEcCtD
Drospirenone—Cerebrovascular accident—Sunitinib—pancreatic cancer	0.00187	0.00925	CcSEcCtD
Drospirenone—Embolism venous—Doxorubicin—pancreatic cancer	0.00177	0.0088	CcSEcCtD
Drospirenone—Depression—Tamoxifen—pancreatic cancer	0.00164	0.00814	CcSEcCtD
Drospirenone—Depression—Erlotinib—pancreatic cancer	0.00162	0.00805	CcSEcCtD
Drospirenone—Acute coronary syndrome—Tamoxifen—pancreatic cancer	0.00162	0.00804	CcSEcCtD
Drospirenone—Myocardial infarction—Tamoxifen—pancreatic cancer	0.00161	0.008	CcSEcCtD
Drospirenone—Acute coronary syndrome—Erlotinib—pancreatic cancer	0.00161	0.00796	CcSEcCtD
Drospirenone—Myocardial infarction—Erlotinib—pancreatic cancer	0.0016	0.00791	CcSEcCtD
Drospirenone—Cerebrovascular accident—Irinotecan—pancreatic cancer	0.00154	0.00762	CcSEcCtD
Drospirenone—Embolism—Epirubicin—pancreatic cancer	0.00151	0.00747	CcSEcCtD
Drospirenone—Cerebrovascular accident—Gemcitabine—pancreatic cancer	0.0015	0.00743	CcSEcCtD
Drospirenone—Haemoglobin—Tamoxifen—pancreatic cancer	0.00149	0.00736	CcSEcCtD
Drospirenone—Haemorrhage—Tamoxifen—pancreatic cancer	0.00148	0.00732	CcSEcCtD
Drospirenone—Haemoglobin—Erlotinib—pancreatic cancer	0.00147	0.00728	CcSEcCtD
Drospirenone—Haemorrhage—Erlotinib—pancreatic cancer	0.00146	0.00725	CcSEcCtD
Drospirenone—Depression—Sunitinib—pancreatic cancer	0.00141	0.00697	CcSEcCtD
Drospirenone—Erythema multiforme—Tamoxifen—pancreatic cancer	0.0014	0.00693	CcSEcCtD
Drospirenone—Embolism—Doxorubicin—pancreatic cancer	0.0014	0.00692	CcSEcCtD
Drospirenone—Acute coronary syndrome—Sunitinib—pancreatic cancer	0.00139	0.00689	CcSEcCtD
Drospirenone—Erythema multiforme—Erlotinib—pancreatic cancer	0.00138	0.00685	CcSEcCtD
Drospirenone—Thrombosis—Epirubicin—pancreatic cancer	0.00137	0.00678	CcSEcCtD
Drospirenone—Mental disorder—Erlotinib—pancreatic cancer	0.00128	0.00635	CcSEcCtD
Drospirenone—Haemoglobin—Sunitinib—pancreatic cancer	0.00127	0.00631	CcSEcCtD
Drospirenone—Haemorrhage—Sunitinib—pancreatic cancer	0.00127	0.00627	CcSEcCtD
Drospirenone—Thrombosis—Doxorubicin—pancreatic cancer	0.00127	0.00627	CcSEcCtD
Drospirenone—Erythema multiforme—Sunitinib—pancreatic cancer	0.0012	0.00593	CcSEcCtD
Drospirenone—Angiopathy—Sunitinib—pancreatic cancer	0.00115	0.00569	CcSEcCtD
Drospirenone—Acute coronary syndrome—Irinotecan—pancreatic cancer	0.00114	0.00567	CcSEcCtD
Drospirenone—Myocardial infarction—Irinotecan—pancreatic cancer	0.00114	0.00564	CcSEcCtD
Drospirenone—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.00112	0.00553	CcSEcCtD
Drospirenone—Breast pain—Epirubicin—pancreatic cancer	0.00111	0.0055	CcSEcCtD
Drospirenone—Myocardial infarction—Gemcitabine—pancreatic cancer	0.00111	0.0055	CcSEcCtD
Drospirenone—Mental disorder—Sunitinib—pancreatic cancer	0.00111	0.0055	CcSEcCtD
Drospirenone—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.0011	0.00543	CcSEcCtD
Drospirenone—Myocardial infarction—Fluorouracil—pancreatic cancer	0.00109	0.0054	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00108	0.00533	CcSEcCtD
Drospirenone—Haemoglobin—Irinotecan—pancreatic cancer	0.00105	0.00519	CcSEcCtD
Drospirenone—Haemorrhage—Irinotecan—pancreatic cancer	0.00104	0.00517	CcSEcCtD
Drospirenone—Breast pain—Doxorubicin—pancreatic cancer	0.00103	0.00509	CcSEcCtD
Drospirenone—Migraine—Docetaxel—pancreatic cancer	0.00103	0.00508	CcSEcCtD
Drospirenone—Haemoglobin—Gemcitabine—pancreatic cancer	0.00102	0.00506	CcSEcCtD
Drospirenone—Nervous system disorder—Erlotinib—pancreatic cancer	0.00102	0.00505	CcSEcCtD
Drospirenone—Haemorrhage—Gemcitabine—pancreatic cancer	0.00102	0.00503	CcSEcCtD
Drospirenone—Skin disorder—Erlotinib—pancreatic cancer	0.00101	0.005	CcSEcCtD
Drospirenone—Haemoglobin—Fluorouracil—pancreatic cancer	0.001	0.00497	CcSEcCtD
Drospirenone—Haemorrhage—Fluorouracil—pancreatic cancer	0.000998	0.00495	CcSEcCtD
Drospirenone—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00096	0.00476	CcSEcCtD
Drospirenone—Angiopathy—Irinotecan—pancreatic cancer	0.000946	0.00469	CcSEcCtD
Drospirenone—Breast disorder—Docetaxel—pancreatic cancer	0.000941	0.00467	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000931	0.00462	CcSEcCtD
Drospirenone—Angiopathy—Gemcitabine—pancreatic cancer	0.000921	0.00457	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000906	0.00449	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000897	0.00444	CcSEcCtD
Drospirenone—Nervous system disorder—Sunitinib—pancreatic cancer	0.000882	0.00437	CcSEcCtD
Drospirenone—Skin disorder—Sunitinib—pancreatic cancer	0.000873	0.00433	CcSEcCtD
Drospirenone—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000791	0.00392	CcSEcCtD
Drospirenone—Myocardial infarction—Docetaxel—pancreatic cancer	0.000787	0.0039	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000776	0.00385	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000747	0.0037	CcSEcCtD
Drospirenone—Nervous system disorder—Irinotecan—pancreatic cancer	0.000726	0.0036	CcSEcCtD
Drospirenone—Haemoglobin—Docetaxel—pancreatic cancer	0.000724	0.00359	CcSEcCtD
Drospirenone—Haemorrhage—Docetaxel—pancreatic cancer	0.000721	0.00357	CcSEcCtD
Drospirenone—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000717	0.00355	CcSEcCtD
Drospirenone—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000707	0.00351	CcSEcCtD
Drospirenone—Skin disorder—Gemcitabine—pancreatic cancer	0.000701	0.00347	CcSEcCtD
Drospirenone—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000696	0.00345	CcSEcCtD
Drospirenone—Affect lability—Epirubicin—pancreatic cancer	0.000692	0.00343	CcSEcCtD
Drospirenone—Migraine—Epirubicin—pancreatic cancer	0.000692	0.00343	CcSEcCtD
Drospirenone—Erythema multiforme—Docetaxel—pancreatic cancer	0.000681	0.00338	CcSEcCtD
Drospirenone—Mood swings—Epirubicin—pancreatic cancer	0.000666	0.0033	CcSEcCtD
Drospirenone—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000663	0.00329	CcSEcCtD
Drospirenone—Angiopathy—Docetaxel—pancreatic cancer	0.000654	0.00324	CcSEcCtD
Drospirenone—Migraine—Doxorubicin—pancreatic cancer	0.00064	0.00317	CcSEcCtD
Drospirenone—Affect lability—Doxorubicin—pancreatic cancer	0.00064	0.00317	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000639	0.00317	CcSEcCtD
Drospirenone—Breast disorder—Epirubicin—pancreatic cancer	0.000635	0.00315	CcSEcCtD
Drospirenone—Mental disorder—Docetaxel—pancreatic cancer	0.000631	0.00313	CcSEcCtD
Drospirenone—Nausea—Tamoxifen—pancreatic cancer	0.000624	0.00309	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000623	0.00309	CcSEcCtD
Drospirenone—Nausea—Erlotinib—pancreatic cancer	0.000617	0.00306	CcSEcCtD
Drospirenone—Mood swings—Doxorubicin—pancreatic cancer	0.000616	0.00305	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000612	0.00304	CcSEcCtD
Drospirenone—Breast disorder—Doxorubicin—pancreatic cancer	0.000587	0.00291	CcSEcCtD
Drospirenone—Nausea—Sunitinib—pancreatic cancer	0.000534	0.00265	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00053	0.00263	CcSEcCtD
Drospirenone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000502	0.00249	CcSEcCtD
Drospirenone—Skin disorder—Docetaxel—pancreatic cancer	0.000497	0.00247	CcSEcCtD
Drospirenone—Haemoglobin—Epirubicin—pancreatic cancer	0.000489	0.00242	CcSEcCtD
Drospirenone—Haemorrhage—Epirubicin—pancreatic cancer	0.000486	0.00241	CcSEcCtD
Drospirenone—Erythema multiforme—Epirubicin—pancreatic cancer	0.00046	0.00228	CcSEcCtD
Drospirenone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000452	0.00224	CcSEcCtD
Drospirenone—Haemorrhage—Doxorubicin—pancreatic cancer	0.00045	0.00223	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000442	0.00219	CcSEcCtD
Drospirenone—Angiopathy—Epirubicin—pancreatic cancer	0.000441	0.00219	CcSEcCtD
Drospirenone—Nausea—Irinotecan—pancreatic cancer	0.00044	0.00218	CcSEcCtD
Drospirenone—Nausea—Gemcitabine—pancreatic cancer	0.000429	0.00212	CcSEcCtD
Drospirenone—Mental disorder—Epirubicin—pancreatic cancer	0.000426	0.00211	CcSEcCtD
Drospirenone—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000425	0.00211	CcSEcCtD
Drospirenone—Nausea—Fluorouracil—pancreatic cancer	0.000421	0.00209	CcSEcCtD
Drospirenone—Angiopathy—Doxorubicin—pancreatic cancer	0.000408	0.00202	CcSEcCtD
Drospirenone—Mental disorder—Doxorubicin—pancreatic cancer	0.000394	0.00195	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000358	0.00177	CcSEcCtD
Drospirenone—Nervous system disorder—Epirubicin—pancreatic cancer	0.000339	0.00168	CcSEcCtD
Drospirenone—Skin disorder—Epirubicin—pancreatic cancer	0.000335	0.00166	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000331	0.00164	CcSEcCtD
Drospirenone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000313	0.00155	CcSEcCtD
Drospirenone—Skin disorder—Doxorubicin—pancreatic cancer	0.00031	0.00154	CcSEcCtD
Drospirenone—Nausea—Docetaxel—pancreatic cancer	0.000304	0.00151	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000298	0.00148	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000276	0.00137	CcSEcCtD
Drospirenone—Nausea—Epirubicin—pancreatic cancer	0.000205	0.00102	CcSEcCtD
Drospirenone—Nausea—Doxorubicin—pancreatic cancer	0.00019	0.000941	CcSEcCtD
Drospirenone—PGR—Signaling Pathways—DTX1—pancreatic cancer	0.00013	0.00111	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000128	0.00109	CbGpPWpGaD
Drospirenone—BCHE—Phospholipid metabolism—PTEN—pancreatic cancer	0.000127	0.00108	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MEN1—pancreatic cancer	0.000127	0.00108	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—SMAD4—pancreatic cancer	0.000127	0.00108	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000125	0.00106	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SSTR1—pancreatic cancer	0.000125	0.00106	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000125	0.00106	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	0.000125	0.00106	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PPY—pancreatic cancer	0.000123	0.00104	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000122	0.00104	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000122	0.00104	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—HRAS—pancreatic cancer	0.000121	0.00103	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH4—pancreatic cancer	0.000121	0.00103	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000121	0.00103	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SSTR2—pancreatic cancer	0.00012	0.00102	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000118	0.00101	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000118	0.001	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000117	0.000999	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—NRAS—pancreatic cancer	0.000116	0.000989	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCKBR—pancreatic cancer	0.000116	0.000988	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000115	0.00098	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—HSPA1B—pancreatic cancer	0.000115	0.000979	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000112	0.00095	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CXCL8—pancreatic cancer	0.00011	0.000939	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PRSS1—pancreatic cancer	0.00011	0.000933	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—DTX4—pancreatic cancer	0.000109	0.000929	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GLI1—pancreatic cancer	0.000109	0.000929	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000109	0.000927	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000109	0.000926	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—MYC—pancreatic cancer	0.000108	0.000921	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000107	0.000909	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—AKT1—pancreatic cancer	0.000107	0.000907	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000106	0.000903	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRP1—pancreatic cancer	0.000106	0.000903	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000106	0.000902	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CASP3—pancreatic cancer	0.000106	0.000899	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000105	0.000896	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—EZH2—pancreatic cancer	0.000105	0.000891	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—MYC—pancreatic cancer	0.000105	0.000889	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCND1—pancreatic cancer	0.000103	0.000875	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH3—pancreatic cancer	0.000103	0.000872	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HEY2—pancreatic cancer	0.000102	0.00087	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000101	0.000858	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—KRAS—pancreatic cancer	0.0001	0.000851	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MMP9—pancreatic cancer	9.99e-05	0.000849	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GAST—pancreatic cancer	9.99e-05	0.000849	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	9.76e-05	0.00083	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	9.74e-05	0.000828	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—pancreatic cancer	9.72e-05	0.000827	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—HSPA1A—pancreatic cancer	9.71e-05	0.000826	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MEN1—pancreatic cancer	9.7e-05	0.000825	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	9.68e-05	0.000823	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	9.55e-05	0.000812	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ARG2—pancreatic cancer	9.51e-05	0.000809	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SCT—pancreatic cancer	9.47e-05	0.000805	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HEY1—pancreatic cancer	9.47e-05	0.000805	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NOTCH1—pancreatic cancer	9.35e-05	0.000795	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH4—pancreatic cancer	9.19e-05	0.000782	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	9.09e-05	0.000773	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCK—pancreatic cancer	9.03e-05	0.000768	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	9.02e-05	0.000767	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	9.01e-05	0.000767	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRSS1—pancreatic cancer	9.01e-05	0.000767	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ZNRF3—pancreatic cancer	9.01e-05	0.000767	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—GCG—pancreatic cancer	9.01e-05	0.000766	CbGpPWpGaD
Drospirenone—BCHE—Phospholipid metabolism—PIK3CA—pancreatic cancer	8.98e-05	0.000764	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARG—pancreatic cancer	8.83e-05	0.000751	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CNR2—pancreatic cancer	8.8e-05	0.000749	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GLP1R—pancreatic cancer	8.8e-05	0.000749	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HSPA1B—pancreatic cancer	8.77e-05	0.000746	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCKAR—pancreatic cancer	8.66e-05	0.000736	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	8.51e-05	0.000723	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—HRAS—pancreatic cancer	8.51e-05	0.000723	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JAG2—pancreatic cancer	8.4e-05	0.000714	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TYMP—pancreatic cancer	8.31e-05	0.000707	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	8.29e-05	0.000705	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MEN1—pancreatic cancer	8.27e-05	0.000704	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MYC—pancreatic cancer	8.25e-05	0.000702	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TGFB1—pancreatic cancer	8.23e-05	0.0007	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	8.17e-05	0.000695	CbGpPWpGaD
Drospirenone—PTGS2—Disease—DTX1—pancreatic cancer	8.15e-05	0.000693	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—EGFR—pancreatic cancer	8.07e-05	0.000686	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	8.02e-05	0.000682	CbGpPWpGaD
Drospirenone—AR—Gene Expression—EZH2—pancreatic cancer	7.98e-05	0.000679	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SHH—pancreatic cancer	7.89e-05	0.000671	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH4—pancreatic cancer	7.84e-05	0.000667	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH3—pancreatic cancer	7.82e-05	0.000665	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IAPP—pancreatic cancer	7.8e-05	0.000663	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SMAD4—pancreatic cancer	7.73e-05	0.000657	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	7.69e-05	0.000654	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PRSS1—pancreatic cancer	7.55e-05	0.000642	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTHLH—pancreatic cancer	7.48e-05	0.000636	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTCH1—pancreatic cancer	7.48e-05	0.000636	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HSPA1A—pancreatic cancer	7.4e-05	0.00063	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	7.19e-05	0.000611	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	7e-05	0.000595	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	6.93e-05	0.000589	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.86e-05	0.000583	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SST—pancreatic cancer	6.84e-05	0.000582	CbGpPWpGaD
Drospirenone—PTGS2—Disease—DTX4—pancreatic cancer	6.83e-05	0.000581	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	6.78e-05	0.000576	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	6.77e-05	0.000576	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	6.75e-05	0.000574	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GLP1R—pancreatic cancer	6.7e-05	0.00057	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JAG1—pancreatic cancer	6.7e-05	0.00057	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH3—pancreatic cancer	6.67e-05	0.000567	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPP2R5B—pancreatic cancer	6.64e-05	0.000565	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—DPYD—pancreatic cancer	6.59e-05	0.00056	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ARG2—pancreatic cancer	6.54e-05	0.000557	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HEY2—pancreatic cancer	6.4e-05	0.000544	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—MYC—pancreatic cancer	6.37e-05	0.000541	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CNR1—pancreatic cancer	6.32e-05	0.000537	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	6.26e-05	0.000533	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC2A2—pancreatic cancer	6.25e-05	0.000532	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.19e-05	0.000526	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	6.17e-05	0.000525	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	6.1e-05	0.000519	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GCG—pancreatic cancer	6.1e-05	0.000519	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.97e-05	0.000508	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HEY1—pancreatic cancer	5.92e-05	0.000504	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SMAD4—pancreatic cancer	5.89e-05	0.000501	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AGTR1—pancreatic cancer	5.82e-05	0.000495	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STK11—pancreatic cancer	5.74e-05	0.000488	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TYMP—pancreatic cancer	5.72e-05	0.000486	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH1—pancreatic cancer	5.7e-05	0.000484	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	5.61e-05	0.000477	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	5.6e-05	0.000476	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	5.49e-05	0.000467	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.44e-05	0.000463	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—pancreatic cancer	5.38e-05	0.000457	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JAG2—pancreatic cancer	5.25e-05	0.000447	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.23e-05	0.000445	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	5.19e-05	0.000441	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MEN1—pancreatic cancer	5.18e-05	0.00044	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC2A2—pancreatic cancer	5.14e-05	0.000437	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—pancreatic cancer	5.03e-05	0.000428	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SMAD4—pancreatic cancer	5.02e-05	0.000427	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SHH—pancreatic cancer	4.94e-05	0.00042	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HES1—pancreatic cancer	4.9e-05	0.000417	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IAPP—pancreatic cancer	4.88e-05	0.000415	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—pancreatic cancer	4.85e-05	0.000412	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CD44—pancreatic cancer	4.84e-05	0.000412	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.77e-05	0.000405	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.74e-05	0.000403	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP2—pancreatic cancer	4.74e-05	0.000403	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—HRAS—pancreatic cancer	4.73e-05	0.000402	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.72e-05	0.000401	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.7e-05	0.0004	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HSPA1B—pancreatic cancer	4.68e-05	0.000398	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GCG—pancreatic cancer	4.64e-05	0.000395	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GLP1R—pancreatic cancer	4.61e-05	0.000392	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.61e-05	0.000392	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—DPYD—pancreatic cancer	4.54e-05	0.000386	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—STK11—pancreatic cancer	4.37e-05	0.000371	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH1—pancreatic cancer	4.34e-05	0.000369	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC2A2—pancreatic cancer	4.3e-05	0.000366	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TERT—pancreatic cancer	4.3e-05	0.000366	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.26e-05	0.000362	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JAG1—pancreatic cancer	4.19e-05	0.000356	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.11e-05	0.00035	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIF1A—pancreatic cancer	4.11e-05	0.00035	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TSC2—pancreatic cancer	4.1e-05	0.000349	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.1e-05	0.000349	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—pancreatic cancer	4.1e-05	0.000348	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOE—pancreatic cancer	4.01e-05	0.000341	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD44—pancreatic cancer	3.98e-05	0.000339	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HSPA1A—pancreatic cancer	3.95e-05	0.000336	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—pancreatic cancer	3.94e-05	0.000335	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KDR—pancreatic cancer	3.93e-05	0.000334	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.89e-05	0.000331	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TYMS—pancreatic cancer	3.76e-05	0.000319	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.74e-05	0.000318	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NFKBIA—pancreatic cancer	3.74e-05	0.000318	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH1—pancreatic cancer	3.7e-05	0.000315	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CTNNB1—pancreatic cancer	3.63e-05	0.000309	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CG—pancreatic cancer	3.62e-05	0.000308	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGF—pancreatic cancer	3.58e-05	0.000304	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—pancreatic cancer	3.49e-05	0.000297	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CD44—pancreatic cancer	3.33e-05	0.000284	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.26e-05	0.000278	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GCG—pancreatic cancer	3.2e-05	0.000272	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CD—pancreatic cancer	3.18e-05	0.000271	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SMAD4—pancreatic cancer	3.14e-05	0.000267	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HES1—pancreatic cancer	3.07e-05	0.000261	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—pancreatic cancer	3.06e-05	0.000261	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOE—pancreatic cancer	3.05e-05	0.00026	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—STK11—pancreatic cancer	3e-05	0.000256	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.89e-05	0.000246	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.82e-05	0.00024	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CB—pancreatic cancer	2.77e-05	0.000236	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CG—pancreatic cancer	2.76e-05	0.000234	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TERT—pancreatic cancer	2.69e-05	0.000229	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—pancreatic cancer	2.67e-05	0.000227	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—pancreatic cancer	2.66e-05	0.000226	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TYMS—pancreatic cancer	2.58e-05	0.00022	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIF1A—pancreatic cancer	2.57e-05	0.000219	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TSC2—pancreatic cancer	2.56e-05	0.000218	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP3—pancreatic cancer	2.55e-05	0.000217	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOE—pancreatic cancer	2.51e-05	0.000213	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—pancreatic cancer	2.48e-05	0.000211	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CTNNB1—pancreatic cancer	2.46e-05	0.000209	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CD—pancreatic cancer	2.42e-05	0.000206	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—pancreatic cancer	2.41e-05	0.000205	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTEN—pancreatic cancer	2.4e-05	0.000204	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—pancreatic cancer	2.33e-05	0.000199	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOTCH1—pancreatic cancer	2.32e-05	0.000197	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGF—pancreatic cancer	2.24e-05	0.00019	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SRC—pancreatic cancer	2.22e-05	0.000189	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—pancreatic cancer	2.17e-05	0.000184	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT3—pancreatic cancer	2.14e-05	0.000182	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRAS—pancreatic cancer	2.14e-05	0.000182	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—pancreatic cancer	2.13e-05	0.000181	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CB—pancreatic cancer	2.11e-05	0.00018	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOE—pancreatic cancer	2.1e-05	0.000179	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—pancreatic cancer	2.09e-05	0.000178	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—pancreatic cancer	1.99e-05	0.000169	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CD—pancreatic cancer	1.99e-05	0.000169	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.99e-05	0.000169	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—pancreatic cancer	1.99e-05	0.000169	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—pancreatic cancer	1.95e-05	0.000166	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CG—pancreatic cancer	1.9e-05	0.000161	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KRAS—pancreatic cancer	1.84e-05	0.000157	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—pancreatic cancer	1.83e-05	0.000156	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTEN—pancreatic cancer	1.82e-05	0.000155	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CB—pancreatic cancer	1.74e-05	0.000148	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	1.69e-05	0.000144	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CD—pancreatic cancer	1.67e-05	0.000142	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—pancreatic cancer	1.64e-05	0.000139	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—pancreatic cancer	1.62e-05	0.000138	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRAS—pancreatic cancer	1.56e-05	0.000133	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CTNNB1—pancreatic cancer	1.54e-05	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PTEN—pancreatic cancer	1.5e-05	0.000128	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CB—pancreatic cancer	1.45e-05	0.000124	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SRC—pancreatic cancer	1.39e-05	0.000118	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—pancreatic cancer	1.38e-05	0.000118	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT3—pancreatic cancer	1.34e-05	0.000114	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NRAS—pancreatic cancer	1.34e-05	0.000114	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—pancreatic cancer	1.29e-05	0.000109	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTEN—pancreatic cancer	1.26e-05	0.000107	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—pancreatic cancer	1.25e-05	0.000106	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—pancreatic cancer	1.24e-05	0.000106	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—pancreatic cancer	1.22e-05	0.000104	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KRAS—pancreatic cancer	1.15e-05	9.8e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—pancreatic cancer	1.06e-05	9e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—pancreatic cancer	1.05e-05	8.95e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HRAS—pancreatic cancer	9.79e-06	8.33e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—pancreatic cancer	8.86e-06	7.54e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—pancreatic cancer	8.64e-06	7.35e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—pancreatic cancer	7.24e-06	6.16e-05	CbGpPWpGaD
